162 related articles for article (PubMed ID: 31473273)
1. EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer.
Qi YF; Liu M; Zhang Y; Liu W; Xiao H; Luo B
Virus Res; 2019 Oct; 272():197735. PubMed ID: 31473273
[TBL] [Abstract][Full Text] [Related]
2. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.
Huang X; Zhang M; Zhang Z
Curr Cancer Drug Targets; 2024; 24(2):127-141. PubMed ID: 37183458
[TBL] [Abstract][Full Text] [Related]
3. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
Guasparri I; Bubman D; Cesarman E
Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
[TBL] [Abstract][Full Text] [Related]
5. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer.
Jiang Y; Xiao H; Sun L; Zhang Y; Liu S; Luo B
Virus Res; 2021 May; 297():198399. PubMed ID: 33753181
[TBL] [Abstract][Full Text] [Related]
6. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
7. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review.
Ribeiro J; Oliveira C; Malta M; Sousa H
Future Oncol; 2017 Mar; 13(6):567-579. PubMed ID: 28118740
[TBL] [Abstract][Full Text] [Related]
11. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma.
Wang J; Liu W; Zhang X; Zhang Y; Xiao H; Luo B
Virology; 2019 Aug; 534():87-95. PubMed ID: 31220652
[TBL] [Abstract][Full Text] [Related]
12. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in Epstein-Barr virus-associated gastric carcinoma.
Yasui M; Kunita A; Numakura S; Uozaki H; Ushiku T; Fukayama M
Cancer Sci; 2020 Jul; 111(7):2598-2607. PubMed ID: 32338409
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma.
Zhang Y; Liu W; Zhang W; Wang W; Song Y; Xiao H; Luo B
Virology; 2019 Jun; 532():1-10. PubMed ID: 30974373
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus miRNA-BART16 modulates cell proliferation by targeting LMP1.
Zhang Y; Zhang W; Liu W; Liu H; Zhang Y; Luo B
Virus Res; 2018 Sep; 256():38-44. PubMed ID: 30077726
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
17. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines.
Li J; Liu X; Liu M; Che K; Luo B
Dig Liver Dis; 2016 Jun; 48(6):673-80. PubMed ID: 27026080
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis.
Morales-Sanchez A; Fuentes-Panana EM
Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953
[TBL] [Abstract][Full Text] [Related]
20. Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells.
Sato Y; Ochiai S; Murata T; Kanda T; Goshima F; Kimura H
Oncotarget; 2017 Jun; 8(24):39345-39355. PubMed ID: 28454117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
